CD300C and infection: Alternatively, if there exists a pathogen which encodes LIR, for which infection mortality is specifically reduced in hosts where IKKγ lacks LIR (Effect IIIb), theoretically this alone could overcome the cost of maintaining pathways to degrade IKKγ by ubiquitin tagging and allow host type 3 to dominate (Fig. 9a, top right hand panel).